## Abstract Peroxisome proliferator‐activated receptor‐gamma (PPAR‐γ) is a member of the nuclear hormone receptor superfamily of ligand‐activated transcription factors and a crucial regulator of cellular differentiation. PPAR‐γ ligands have been demonstrated to inhibit growth of several cancer cell
Inhibition of Lymphoma Cell Proliferation by Peroxisomal Proliferator-Activated Receptor-γ Ligands via Wnt Signaling Pathway
✍ Scribed by Jia-Jun Liu; Xue-Jun Dai; Yan Xu; Pei-Qing Liu; Yong Zhang; Xiao-Dan Liu; Zhi-Gang Fang; Dong-Jun Lin; Ruo-Zhi Xiao; Ren-Wei Huang; He-Qing Huang
- Publisher
- Springer-Verlag
- Year
- 2011
- Tongue
- English
- Weight
- 537 KB
- Volume
- 62
- Category
- Article
- ISSN
- 1085-9195
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND Ligand activation of peroxisome proliferator‐activated receptor γ (PPARγ) results in the inhibition of proliferation of various cancer cells. The aim of this study is to investigate the mechanisms of cell growth inhibition of hepatocellular carcinoma (HCC) cell lines by t
Peroxisome proliferator-activated receptor ␥ (PPAR␥) is expressed largely in adipose tissues and plays an important role in adipocyte differentiation. Several studies have recently shown that ligands of PPAR␥ could lead to growth inhibition in some malignancies. In our study, we focused on pancreati